DASI Dimensions vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by DASI Simulations
VS
by Pathway Labs

AI Verdict

DASI Dimensions and EchoNext are adjacent tools in the cardiology AI space, both FDA-cleared and focused on cardiac health. DASI Dimensions specializes in pre-procedural planning for TAVR using CT scans, offering precise measurements and visualizations of cardiac structures. In contrast, EchoNext analyzes standard ECGs to detect hidden structural heart disease, including heart failure and valve disease, providing non-invasive diagnostic support.

Choose DASI Dimensions if…

Choose DASI Dimensions if your cardiology department requires precise, AI-powered pre-procedural planning for Transcatheter Aortic Valve Replacement (TAVR) procedures. This tool is ideal for cardiothoracic surgeons and interventional cardiologists who need detailed, patient-specific computational models and measurements from CT scans to enhance decision-making and streamline surgical workflows. Its 'pay per analysis' model makes it suitable for practices seeking advanced imaging analysis without a recurring subscription fee.

View DASI Dimensions →

Choose EchoNext if…

Choose EchoNext if your practice or hospital aims to broadly screen for hidden structural heart disease using standard ECGs, particularly in primary care, internal medicine, or general cardiology settings. This AI tool is best suited for identifying risks of heart failure, valve disease, and pulmonary hypertension non-invasively, offering a cost-effective monthly subscription for early detection and clinical decision support across a wide patient population.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature DASI Dimensions EchoNext
Pricing Pay per analysis Starts at $600/month
Deployment Cloud-based Available through the OpenEvidence clinical decision support platform.
BAA Available Unknown Yes AI-estimated
FDA Status 1 AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DASI Dimensions

DASI Dimensions has undergone Human Factors/Usability Validation, which showed its user interface is user-friendly and reduces use-related risk. EchoNext's deployment through the OpenEvidence platform suggests a potentially broader reach, but specific usability validation details are not provided in the available information.

Clinical Value

EchoNext

EchoNext has demonstrated superior accuracy in detecting structural heart disease from ECGs compared to cardiologists, even those assisted by AI. It has also been credited with guiding patient care leading to a heart transplant, showcasing a direct impact on patient outcomes. DASI Dimensions focuses on pre-procedural planning for TAVR, aiming to improve decision-making and patient outcomes, but lacks comparative performance data against human experts in the provided information.

Pricing & Value

DASI Dimensions

DASI Dimensions offers a 'pay per analysis' model with no implementation or subscription fees, which can be more cost-effective for varying usage volumes. EchoNext has tiered pricing starting at $600/month, plus a 10% implementation fee for most plans, which could be a higher barrier to entry for some practices.

Enterprise Readiness

EchoNext

EchoNext is available through the OpenEvidence clinical decision support platform, which is used by 650,000 U.S. physicians, indicating a strong existing infrastructure for broad deployment and integration within enterprise healthcare systems. While DASI Dimensions is cloud-based and offers human-in-the-loop quality checks, its enterprise integration capabilities are not as explicitly detailed.

Innovation

EchoNext

EchoNext represents a significant innovation by utilizing standard ECGs to detect hidden structural heart disease, a capability that previously required more expensive and less accessible imaging. This approach has the potential to create an entirely new screening paradigm for heart disease. DASI Dimensions offers AI-powered image post-processing and patient-specific computational models, which are innovative for TAVR planning, but EchoNext's application to a widely available and inexpensive test for early disease detection stands out as more broadly transformative.

Support & Docs

Tie

Both tools are FDA-cleared, implying a certain level of documentation and validation. However, specific details regarding ongoing customer support, training materials, or comprehensive documentation are not provided for either tool in the given information or web search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature DASI Dimensions EchoNext
Tool Name DASI Dimensions EchoNext
Company DASI Simulations Pathway Labs
Description FDA-cleared, AI-powered imaging software that provides precise measurements and visualizations of cardiac structures from CT scans for pre-procedural planning of Transcatheter Aortic Valve Replacement (TAVR) procedures, enhancing decision-making and patient outcomes. FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Key Features AI-powered image post-processing for cardiac structures; Pre-procedural planning for Transcatheter Aortic Valve Replacement (TAVR); Provides pre-defined images and measurements (diameters, lengths, angles, areas, perimeters) of cardiovascular structures; Cloud-based software; Eliminates time spent on manual landmark identification and measurements; Human-in-the-loop quality checks for accuracy and reliability; Interactive simulation results; Patient-specific computational models of the heart. AI-powered ECG analysis; Detection of hidden structural heart disease; Identifies heart failure risk; Screens for valve disease; Detects pulmonary hypertension indicators; Utilizes standard 12-lead ECGs; FDA-cleared technology; Non-invasive diagnostic support.

Videos

Demos, reviews, and walkthroughs featuring DASI Dimensions and EchoNext.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

DASI Dimensions is a cloud-based software that eliminates manual landmark identification and measurements for TAVR planning, integrating into the existing heart team process seamlessly. EchoNext is available through the OpenEvidence clinical decision support platform, which is used by over 500,000 physicians, aiming to integrate into tools physicians already use at the point of care.
DASI Dimensions provides precise measurements and visualizations of cardiac structures from CT scans for TAVR planning, with its AI trained on a multi-center dataset and ground-truthed by cardiologists specializing in cardiac imaging. EchoNext accurately identified 77% of structural heart problems from ECGs alone in a 2025 study, outperforming cardiologists who were 64% accurate, and was trained on over 700,000 paired ECG and echocardiogram records.
DASI Dimensions aims to eliminate time spent on manual tasks, suggesting a focus on efficiency once integrated, and its related product, PrecisionTAVI, has a very small learning curve for interpretation. EchoNext analyzes standard 12-lead ECGs, a routine test, and its integration with the OpenEvidence platform suggests a focus on accessibility within existing physician tools.
For DASI Dimensions, DASI Simulations offers technical overviews and assistance with workflow and integration. While specific training details for EchoNext are not provided, its availability through the OpenEvidence platform implies support within that ecosystem, and Pathway Labs is expanding into more health systems.
DASI Dimensions is specifically designed for pre-procedural planning of Transcatheter Aortic Valve Replacement (TAVR) procedures, providing patient-specific computational models and predictive insights to reduce complications and optimize outcomes. EchoNext, on the other hand, analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension, serving as an early screening tool to identify patients who should proceed to an echocardiogram.
AI Tool Finder
AI-powered search. Results may not be comprehensive.